The Biden administration's extension of the COVID-19 emergency declaration until 2029 raises critical questions about accountability and the influence of pharmaceutical companies. Discover the implications of this controversial decision and the concerns it has sparked among critics.
Greek 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)